Trupanion, Inc.
TRUP- Exchange
- Nasdaq
- Industry
- Hospital & Medical Service Plans
- SEC CIK
- 0001371285
In the last 90 days, Trupanion, Inc. insiders filed 0 open-market purchases and 7 sales; 200 institutions reported holding it in 13F filings for Q2 2026, worth $836.4M in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Trupanion, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 7 filings
- 3 insiders, $380.2K in total
- Insiders trading
- 3
- Net value
- −$380.2K
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Trupanion, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Gallagher John R | Chief Operating Officer | 33,311 | Sep 30, 2026 | 17 |
| Tooth Margaret | CEO | 185,952 | Sep 15, 2026 | 10 |
| Rubin Howard E | Director | 233,288 | Aug 26, 2026 | 5 |
| Powell Bradley S | Director | 3,546 | Aug 26, 2026 | 6 |
| Bearman Asher | Chief Legal Officer | 74,013 | Aug 26, 2026 | 4 |
| Weinrauch Steve | EVP, North Am & Vet Strategy | 81,740 | Aug 26, 2026 | 7 |
| McGibney Brenna | Chief Administration Officer | 14,437 | Aug 26, 2026 | 6 |
| Wheeler Simon | EVP, Trupanion International | 25,327 | Aug 26, 2026 | 6 |
| Qureshi Fawwad | Chief Financial Officer | 4,230 | Aug 26, 2026 | 7 |
| Rawlings Darryl | Director | 25,151 | Aug 26, 2026 | 8 |
| McLaughlin Elizabeth | Director | 10,635 | May 13, 2026 | 1 |
| Dodson Paulette R. | Director | 8,526 | May 13, 2026 | 1 |
| Broden Max | Director | 8,571 | May 13, 2026 | 1 |
| Dreyer Emily | Chief Revenue Officer | 35,627 | Mar 6, 2026 | 5 |
| Low Murray B | Director | 154,534 | Jan 12, 2026 | 1 |
| Kearns Christopher J | Chief Legal Officer | 8,159 | Mar 3, 2025 | 0 |
| Hewitt Melissa Joy | General Manager | 9,779 | Mar 3, 2025 | 0 |
| Wasdin Jason | General Manager | 4,553 | Mar 3, 2025 | 0 |
| Davidson Jacqueline L | Director | 16,564 | Jan 3, 2025 | 0 |
| Worra Travis | General Manager | 4,179 | Nov 27, 2024 | 0 |
| Raval Kalpesh | General Manager | 3,886 | Nov 27, 2024 | 0 |
| Levitan Dan | Director | 95,116 | Apr 3, 2024 | 0 |
| Satchu Zay | Director | 4,788 | Apr 3, 2024 | 0 |
| Enthoven Richard | Director | 485 | Jan 3, 2024 | 0 |
| Doak Michael | Director | 5,866 | Sep 1, 2023 | 0 |
| Li Wei | Interim CFO | 4,909 | Aug 29, 2023 | 0 |
| Wolff Andrew D. | Chief Financial Officer | 7,895 | May 30, 2023 | 0 |
| Plouf Tricia | EVP, Pricing | 41,023 | Feb 10, 2023 | 0 |
| Friedman Gavin | EVP, Legal and Regulatory | 9,591 | Feb 3, 2023 | 0 |
| Johnson Eric L | Director | 2,691 | Jan 4, 2023 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 25, 2021 (view filing) | Oct 21 | 4 days | Low Murray BDirector | SSale | −1.00K | $110.50 | −$110.5K | −0.7%134.5K after | 2 lots |
| Oct 12, 2021 (view filing) | Oct 7 | 5 days | Rawlings DarrylCEO | SSale | −4.00K | $83.78 | −$335.1K | −0.4%971.2K after | |
| Oct 5, 2021 (view filing) | Oct 1 | 4 days | Friedman GavinEVP, People and Legal | SSale | −400 | $78.30 | −$31.3K | −32.6%826 after | |
| Oct 4, 2021 (view filing) | Sep 30 | 4 days | Plouf TriciaCo-President and CFO | SSale | −3.50K | $79.81 | −$279.3K | −10.6%29.6K after | 6 lots |
| Sep 30, 2021 (view filing) | Sep 28 | 2 days | Tooth MargaretCo-President | SSale | −300 | $85.29 | −$25.6K | −1.6%18.7K after | |
| Sep 23, 2021 (view filing) | Sep 22 | 1 day | Rawlings DarrylCEO | SSale | −4.00K | $83.97 | −$335.9K | −0.4%975.2K after | |
| Sep 9, 2021 (view filing) | Sep 7 | 2 days | Rawlings DarrylCEO | SSale | −4.00K | $86.56 | −$346.2K | −0.4%979.2K after | |
| Sep 3, 2021 (view filing) | Sep 1 | 2 days | Friedman GavinEVP, People and Legal | SSale | −400 | $92.00 | −$36.8K | −24.6%1.23K after | |
| Sep 1, 2021 (view filing) | Aug 30 | 2 days | Doak MichaelDirector | SSale | −2.50K | $94.91 | −$237.3K | −100.0%0 after | |
| Aug 31, 2021 (view filing) | Aug 27 | 4 days | Tooth MargaretCo-President | SSale | −250 | $90.00 | −$22.5K | −1.3%19.0K after | |
| Aug 23, 2021 (view filing) | Aug 19 | 4 days | Rawlings DarrylCEO | SSale | −4.00K | $86.36 | −$345.4K | −0.4%983.2K after | |
| Aug 23, 2021 (view filing) | Aug 19 | 4 days | Plouf TriciaCo-President and CFO | SSale | −1.50K | $85.73 | −$128.6K | −4.6%30.8K after | |
| Aug 5, 2021 (view filing) | Aug 3 | 2 days | Rawlings DarrylCEO | SSale | −4.00K | $113.83 | −$455.3K | −0.4%987.2K after | |
| Aug 4, 2021 (view filing) | Aug 2 | 2 days | Friedman GavinEVP, People and Legal | SSale | −400 | $115.78 | −$46.3K | −19.7%1.63K after | |
| Jul 30, 2021 (view filing) | Jul 28 | 2 days | Tooth MargaretCo-President | SSale | −250 | $114.07 | −$28.5K | −1.3%19.2K after | |
| Jul 28, 2021 (view filing) | Jul 26 | 2 days | Low Murray BDirector | SSale | −500 | $115.24 | −$57.6K | −0.4%126.4K after | |
| Jul 19, 2021 (view filing) | Jul 16 | 3 days | Rawlings DarrylCEO | SSale | −4.00K | $105.07 | −$420.3K | −0.4%991.2K after | |
| Jul 19, 2021 (view filing) | Jul 15 | 4 days | Plouf TriciaCo-President and CFO | SSale | −1.50K | $104.79 | −$157.2K | −4.6%30.8K after | |
| Jul 14, 2021 (view filing) | Jul 12 | 2 days | Low Murray BDirector | SSale | −500 | $113.80 | −$56.9K | −0.4%126.9K after | |
| Jul 2, 2021 (view filing) | Jul 1 | 1 day | Friedman GavinEVP, People and Legal | SSale | −400 | $115.60 | −$46.2K | −16.5%2.03K after | |
| Jul 2, 2021 (view filing) | Jun 30 | 2 days | Rawlings DarrylCEO | SSale | −4.00K | $115.81 | −$463.2K | −0.4%995.2K after |